Welcome to PsychiatryAI.com: [PubMed] - Psychiatry AI Latest

Developing a Cost-Effectiveness Model of Digital Therapeutics for Smoking Cessation

Evidence

Stud Health Technol Inform. 2024 Jan 25;310:1548-1549. doi: 10.3233/SHTI231287.

ABSTRACT

The purpose of this research was to construct a Markov model of digital therapeutics to predict the lifetime costs and consequences that would be incurred by a hypothetical group of adult smokers in Korea who only made a single attempt to stop smoking. To determine the efficacy of DTx, we created an annual cycle Markov model. The result shows that the NRT strategy is determined as the dominant strategy. Digital therapeutics acts as a complement to pharmacotherapy and is a low-cost option.

PMID:38269739 | DOI:10.3233/SHTI231287

Document this CPD Copy URL Button

Google

Google Keep Add to Google Keep

LinkedIn Share Share on Linkedin Share on Linkedin

Estimated reading time: 2 minute(s)

Latest: Psychiatryai.com #RAISR4D

Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️

Real-Time Evidence Search [Psychiatry]

AI Research [Andisearch.com]

Developing a Cost-Effectiveness Model of Digital Therapeutics for Smoking Cessation

Copy WordPress Title

🌐 90 Days

Evidence Blueprint

Developing a Cost-Effectiveness Model of Digital Therapeutics for Smoking Cessation

QR Code

☊ AI-Driven Related Evidence Nodes

(recent articles with at least 5 words in title)

More Evidence

Developing a Cost-Effectiveness Model of Digital Therapeutics for Smoking Cessation

🌐 365 Days

Floating Tab
close chatgpt icon
ChatGPT

Enter your request.